Atrás
Precio Abivax SA (ABVX)
Gráfico del Precio de Acciones ABVX
ABVX Ganando
Abivax SA
$117.1
0.25%
$0.29
Al cierre: Jan 16, 16:00:00 GMT-5
$125
6.74%
$7.9
Mercado Previo: Jan 20, 05:29:56 GMT-5
Estadísticas clave
Cierre Anterior
$116.8
Precio de apertura
$116.79
Rango del día
$116.02 - $125
Rango de 52 semanas
$4.77 - $148.83
Volumen
779.6K
Volumen promedio
1.6M
EPS (TTM)
-3.62
Rendimiento de dividendos
--
Cap. de mercado
$9.7B
¿Qué es ABVX?
Abivax SA engages in the sale, research, distribution, and development of biopharmaceutical products. The company is headquartered in Paris, Ile-De-France and currently employs 69 full-time employees. The company went IPO on 2015-06-26. ABIVAX utilizes RNA-protein interaction interference and cytotoxic TH1 cell amplification to generate therapies to help patients clear viruses like HIV, HBV and HPV. The firm's product pipeline comprises ABX 203, which is the therapeutic vaccine candidate obtained from the Centre for Genetic Engineering and Biotechnology, Cuba (CIGB) and is intended for patients with chronic hepatitis B disease; and ABX196, the adjuvant for therapeutic vaccines, among others.
Características
Estrategias de Trading
© 2025 Finture Development Limited. All rights reserved